House Lawmakers Joust Over Drug Pricing Transparency Bills
A powerful House panel on Tuesday scrutinized bipartisan bills that would demand justification for pharmaceutical price increases, although fissures emerged over whether the transparency would be "burdensome" or if drugmakers were...To view the full article, register now.
Already a subscriber? Click here to view full article